Accessibility Options
Skip to main content
|
Skip to menu
A-
A
A+
A
A
Accessibility features
Home
|
Contact Us
MEDIA
RTI
TENDERS
FAQ'S
VACANCIES
LINKS
ALERTS
Search ...
SEARCH
About FDA
Food & Drug Control Organization
Our Vision ,Mission & Values
History Of FDA
Role of FDA
Organizational Chart
Citizen Charter
Hyperlink Policy
Copyright Policy
Consumer Awareness
Do's and Dont's of Food
Fake Medicine 1
Fake Medicine 2
Guideline For Handcarts/Gaddas/Kiosks
Safe Food Guidelines
Prescription Poster
Do's and Dont's of Drugs
Quick test for Common adulterants in food
Writing & Handling of Prescriptions
Basics of Food Safety
Guide to Safe Use of Medicines
The Pink Book Your Guide for SNF @ Home
Legislation
Acts & Rules
Forms
Drug Price Control Order
News & Events
FDA Events and Happenings
FDA Directory
Officers Directory
Manufacturers
Retailers Directory
Wholesalers Directory
Blood Banks
Blood Storage Centers
Schedule X License Holder
Circulars, Orders & Notifications
Circulars
Orders
Notifications
Contact Us
Location Map
Contact FDA Personnel
Feedback
Help
ROLE OF FDA
Drug
Cosmetics
Food
Laboratory
You are here:
Home
NOTIFICATIONS
NOTIFICATIONS
Notification S.O. 1851, 1852, 1853, 1854,& 1855.
Notification no GSR 328(E) dated 03/04/2017
Notification no GSR 367 (E) dated 13/04/2017
Final Notification on Compulsory submission of Bio equivalence Study Data
SUSPENSION OF MANUFACTURE FOR SALE , SALE AND DISTRIBUTION OF DEXTROPROPOXYPHENE AND ITS FORMULATIONS
Revocation of the suspension of the notification G.S.R. No. 379(E) dated 18/06/2013 as regards to maufacture for sale, sale and distribution of Pioglitazone for human use
Revised Notification under Goa Public Health Amendment Act, 2005
Notification under Goa Public Health Amendment Act, 2005
Sub-rule 3A of Rule 97 of Drugs and Cosmetics Rules 1945 regarding withdrawal period
Schedule H-1 Notified
Page 2 of 6
1
2
3
4
...
6
Accessibility Options